Sensitivity of human meningioma cells to the cyclin-dependent kinase inhibitor, TG02

Sensitivity of human meningioma cells to the cyclin-dependent kinase inhibitor, TG02

Standards of care for meningioma include surgical resection and radiotherapy whereas pharmacotherapy plays almost no role in this disease. We generated primary cultures from surgically removed meningiomas to explore the activity of a novel cyclin-dependent kinase inhibitor, TG02, in meningioma cell...

Full description

Bibliographic Details
Main Authors: Caroline von Achenbach, Emilie Le Rhun, Felix Sahm, Sophie S. Wang, Philipp Sievers, Marian C. Neidert, Elisabeth J. Rushing, Tracy Lawhon, Hannah Schneider, Andreas von Deimling, Michael Weller
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:Translational Oncology
Subjects:
Meningioma
TG02
Mutation
Methylation
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523320303442

Internet

http://www.sciencedirect.com/science/article/pii/S1936523320303442

Similar Items